Marshall Wace North America’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-334,147
Closed -$3.41M 1827
2021
Q2
$3.41M Buy
+334,147
New +$3.53M 0.01% 659
2021
Q1
Sell
-13,987
Closed -$127K 1881
2020
Q4
$127K Buy
+13,987
New +$108K ﹤0.01% 1250
2020
Q2
Sell
-35,245
Closed -$256K 1587
2020
Q1
$256K Sell
35,245
-9,283
-21% -$68.8K ﹤0.01% 870
2019
Q4
$394K Buy
+44,528
New +$333K ﹤0.01% 863
2019
Q3
Sell
-143,069
Closed -$598K 1635
2019
Q2
$598K Buy
+143,069
New +$754K ﹤0.01% 857
2018
Q2
Sell
-13,767
Closed -$94K 1816
2018
Q1
$94K Buy
+13,767
New +$87.4K ﹤0.01% 1370
2017
Q4
Sell
-211,287
Closed -$1.27M 1686
2017
Q3
$1.27M Sell
211,287
-402,206
-66% -$2.71M 0.01% 899
2017
Q2
$4.91M Buy
613,493
+572,453
+1,395% +$4.84M 0.04% 504
2017
Q1
$369K Buy
+41,040
New +$428K ﹤0.01% 848

Other funds holding NPTN

Marshall Wace North America's NPTN Position: Q3 2021 in Review

Marshall Wace North America sold out of NEOPHOTONICS CORP (NPTN) in Q3 2021, closing a stake of 334,147 shares — an estimated $3.41M sold.

Marshall Wace North America first reported a position in NPTN in Q1 2017 and held it in 9 quarters. The position peaked at $4.91M in Q2 2017. 124 funds tracked by Wall St. Rank hold NPTN as of Q3 2021.

  • Marshall Wace North America reported no remaining NEOPHOTONICS CORP position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 334,147 NEOPHOTONICS CORP shares in Q3 2021, an estimated $3.41M.
  • Marshall Wace North America first reported a position in NEOPHOTONICS CORP in Q1 2017 and held it in 9 quarters.
  • Marshall Wace North America's NEOPHOTONICS CORP position peaked at $4.91M in Q2 2017.
  • 124 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.